APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 36 filers reported holding APTEVO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58 | -50.4% | 175,980 | +119.5% | 0.00% | – |
| Q2 2023 | $117 | +4.5% | 80,186 | +45.8% | 0.00% | – |
| Q1 2023 | $112 | -26.3% | 54,986 | -16.0% | 0.00% | – |
| Q4 2022 | $152 | -99.9% | 65,486 | -4.2% | 0.00% | – |
| Q3 2022 | $208,000 | -16.8% | 68,386 | -2.1% | 0.00% | – |
| Q2 2022 | $250,000 | -27.7% | 69,886 | +18.7% | 0.00% | – |
| Q1 2022 | $346,000 | -36.0% | 58,886 | -14.3% | 0.00% | -100.0% |
| Q4 2021 | $541,000 | -75.6% | 68,686 | -52.1% | 0.00% | -66.7% |
| Q3 2021 | $2,214,000 | -38.3% | 143,419 | -10.3% | 0.00% | -25.0% |
| Q2 2021 | $3,587,000 | -43.8% | 159,923 | -23.6% | 0.00% | -50.0% |
| Q1 2021 | $6,385,000 | -31.5% | 209,223 | -17.8% | 0.01% | -20.0% |
| Q4 2020 | $9,325,000 | +318.9% | 254,423 | -13.1% | 0.01% | +400.0% |
| Q3 2020 | $2,226,000 | +16.9% | 292,867 | +28.5% | 0.00% | 0.0% |
| Q2 2020 | $1,904,000 | +184.2% | 227,967 | +26.0% | 0.00% | +100.0% |
| Q1 2020 | $670,000 | – | 180,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,760,000 | $39,477,000 | 7.86% |
| RTW INVESTMENTS, LP | 281,402 | $6,312,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 187,995 | $4,217,000 | 0.09% |
| Anson Funds Management LP | 35,587 | $798,000 | 0.08% |
| Alyeska Investment Group, L.P. | 139,172 | $3,122,000 | 0.04% |
| Dynamic Technology Lab Private Ltd | 14,022 | $315,000 | 0.03% |
| JBF Capital, Inc. | 3,907 | $88,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 15,350 | $344,000 | 0.01% |
| Renaissance Technologies | 159,923 | $3,587,000 | 0.00% |
| QS Investors, LLC | 15,650 | $352,000 | 0.00% |